) that were significantly associated with ICAC volume. Rs1537372 replicated in an independent sample of 716 stroke patients (P combined =1.38×10 −10 ). Conclusions-ICAC volume is a heritable trait, which is partly explained by common genetic variation. We identified specific genetic variants associated with ICAC, which given the importance of ICAC in stroke risk, needs replication in larger-scale studies to further elucidate its genetic basis. 
I
ntracranial carotid artery calcification (ICAC) is a leading risk factor for stroke. [1] [2] [3] Various established environmental and lifestyle factors such as smoking and diabetes mellitus are known to contribute substantially to the formation of ICAC. 1, 2, 4 Yet, it remains unknown to what extent genetics play a role in the development of ICAC.
For the last decade, genetic research of atherosclerotic calcification has mainly focused on the coronary arteries given strong relations with coronary morbidity and mortality. Recently, this has led to the identification of 3 common genetic variants strongly related to the presence and amount of coronary artery calcification. 5 Yet, preliminary evidence suggests that these variants are not associated with calcification in other vessels. 6 This suggests that although arterial calcification is a systemic process, there are important vesselspecific differences in its cause. 7, 8 Given that other risk factors such as diabetes mellitus and smoking are generally thought to exert a systemic effect on the formation of arterial calcification, genetic information may be crucial for explaining location-specific differences.
Against this background, it is vital to elucidate the genetic susceptibility underlying the development of ICAC. This information may ultimately aid in the development of therapeutic or preventive interventions for stroke.
Therefore, in this study, we quantified ICAC, 3 determined its heritable component, and performed a genome-wide association study (GWAS) including independent replication of top hits. 
Background and Purpose-Intracranial

Methods
Discovery Cohort
This study was embedded in the Rotterdam study, 9 a prospective population-based study investigating the determinants and consequences of age-related diseases in older adults. The original cohort consisted of 7983 participants 55 years or older and was extended in 2000 to 2001 by 3011 people. At study entry and every 3 to 4 years, all participants are reexamined in a dedicated research center. The Rotterdam study represents a relatively stable, homogeneous middleclass population, largely of European descent. The Rotterdam study has been approved by the medical ethics committee according to the Population Screening Act: Rotterdam study, executed by the Ministry of Health, Welfare and Sports of the Netherlands. All participants provided written informed consent.
Between September 2003 and February 2006, we invited all participant who visited the research center to undergo nonenhanced computed tomography (CT) scanning to quantify calcification in the intracranial carotid arteries (as part of a large project on quantification of vascular calcification in multiple vessel beds). 10, 11 Because of errors in image acquisition or image artifacts, 29 CT examinations from the 2524 were not gradable, leaving a total of 2495 people with a gradable CT examination for ICAC. Of these 2495 people, 2034 were successfully genotyped.
Assessment of ICAC
Noncontrast CT images were obtained using a 16-slice (n=785) or 64-slice (n=1,739) multidetector CT scanner (Somatom Sensation 16 or 64, Siemens, Forchheim, Germany). We performed 2 scans: a cardiac scan and a scan that reached from the aortic arch to the circle of Willis. Using these scans, we imaged the coronary arteries, the aortic arch, the extracranial part of the internal carotid arteries, and intracranial part of the internal carotid arteries. Detailed information on the imaging parameters of the scans is described elsewhere. 8, 11 As marker of intracranial atherosclerosis, we measured ICAC in both internal carotid arteries from the horizontal petrous bone segment up to its top. 3, 4 To quantify ICAC, we used a semiautomated scoring method, which is described in detail elsewhere. 4, 12 In short, all calcifications in the trajectory of the intracranial internal carotid artery were manually delineated in consecutive multidetector CT-slices while making sure that bony structures were not included. Next, the number of pixels >130 Hounsfield units was determined and the calcification volume (mm 3 ) was calculated by multiplying the number of pixels, pixel-size, and the increment.
Calcification volumes in the coronary arteries, aortic arch, and extracranial carotid arteries were quantified using dedicated commercially available software (Syngo CalciumScoring, Siemens, Germany). 8 All calcification volumes are expressed in cubic millimeter.
Genotyping
All study participants were genotyped with the 550K, 550K duo, or 610 quad Illumina arrays. We removed samples with a call rate <97.5%, sex mismatch, excess autosomal heterozygosity (>0.336), duplicates or family-relations, and ethnic outliers. Moreover, we removed those variants with call rates <98.0%, failing missingness tests, Hardy-Weinberg equilibrium P values <10 -6 , and minor allele frequencies (MAF) of <0.1%. Genotypes were imputed using MACH/minimac software to the 1000 Genomes phase I version 3 reference panel (entire population).
Heritability Analysis
We used genome-wide complex trait analysis to estimate heritability in our sample of unrelated individuals. 13 This method is based on comparing the genetic similarity between individuals with their phenotypic similarity, and the heritability estimates refer to the proportion of variance explain by the variants on the genome-wide chip. As previously described, 14 the 1000 genomes imputed genotypes were filtered on imputation quality (R 2 <0.5) and allele frequency (MAF<0.01). We calculated pair wise genetic relatedness between all individuals and removed one person for pairs with >0.02 genotype similarity.
We performed heritability analyses for calcification volume in the 4 vessel beds separately. Moreover, we assessed the proportion of shared heritability between ICAC and calcification in the other 3 vessel beds using the bivariate restricted maximum likelihood function of genome-wide complex trait analysis. Because calcification volume had a skewed distribution, we used natural log-transformed values and added 1.0 mm 3 to the nontransformed values to deal with calcium volumes of 0 [Ln(calcification volume + 1.0 mm 3 )]. We adjusted the analyses for age and sex.
Genome-Wide Association Analyses
We conducted GWAS on calcification in the 4 vessel beds using the R-package ProbABEL (version 0.4.4). 15 Given that measures of subclinical atherosclerosis in the coronary arteries, aortic arch and carotid artery bifurcation have already been studied in larger GWAS (in some instances also including this sample), 5, 16, 17 the main focus was on ICAC. Calcification measures were analyzed under an additive model with linear regression, while adjusting for age and sex. The results were adjusted for genomic control and meta-analyzed using the METAL software. 18 Variants with an R 2 <0.5 and a MAF<0.05 were removed. Genome-wide significance was established at P<5×10 −8 . Manhattan plots and regional association plots were generated in R. For the top variants (P<10 -7 ) and those in linkage disequilibrium (r 2 >0.2), we checked HaploReg (v4.1, http://www.broadinstitute. org/mammals/haploreg/haploreg.php) for indications of functionality (expression quantitative trait loci, promotor and enhancer histone marks, and conservation). Next, we investigated the association of the top variants from the GWAS on ICAC with calcification volume in the other vessel beds.
Replication
Replication of genome-wide significant variants was attempted in the Erasmus Stroke Study (ESS), a clinical transient ischemic attack and stroke registry, in which patients with stroke were enrolled between December 2005 and September 2010, in the Erasmus MC, Rotterdam, the Netherlands and which is described in detail elsewhere. 19 For this study, we used all patients with complete information on ICAC (as assessed by contrast-enhanced multidetector CT angiography) and in whom blood samples were taken (n=776). Of these 776, 716 were successfully genotyped for rs1537372 and 743 for rs1103842. The stroke subtypes according to the TOAST criteria of these participants were as follows: (1) large-vessel disease: 17%, (2) cardioembolism: 12%, (3) small vessel disease: 24%, (4) other: 6%, and (5) undetermined: 42%. Participants were genotyped using Taqman Allelic 
Results
Study Population
The characteristics of the study population are shown in Table 1 . The mean age of the study population was 69.6±6.8 years, and 51.7% were females.
Heritability of ICAC
We found an age-and sex-adjusted heritability for ICAC 
GWAS of ICAC
We performed a GWAS for ICAC volume. Figure 1 ) that showed a suggestive association with ICAC. Table 3 shows the top genetic variants at 3 loci associated with ICAC volume of with P<1×10 −7 . For the 9p21 locus, there is a considerable body of literature on potential functional mechanisms. The top variant of 11p11.2 shows enhancer histone marks in muscle and stomach cell lines. For 2q14.1, several variants in linkage disequilibrium overlap with promotor or enhancer marks or affect gene expression (Table I in the online-only Data Supplement).
Given the known association of the 9p21 locus with ischemic stroke, 20 we performed a sensitivity analysis in which we excluded participants with prevalent clinical stroke from the sample (n=85). This did not attenuate the association of rs1537372 with ICAC volume (β=0.18; P=9.50×10 −9 ). We also repeated the analyses after excluding people without any calcifications, but this did not materially affect the results (Table II in the online-only Data Supplement). Furthermore, we did not identify any interaction with sex.
We also investigated associations of the 3 top variants for ICAC with calcification volume in the coronary arteries, aortic arch, and the extracranial carotid arteries. Figure 2 shows the regional plots for 9p21.3 and 11p11.2. We found that rs1537372 and rs11038042 were related to calcification in at least 2 of the other vessel beds, whereas rs34008603 showed only a single nominally significant association with the extracranial carotid artery (Table 4) .
Replication of Top Variants for ICAC
We were able to replicate our top variant rs1537372 from the locus at 9p21.3 (n=716; β=0.13; P=5.19×10 −3 ). Rs11038042 at 11p11.2 did not replicate in the independent sample (n=731; β=−0.06; P=0.304). Yet, the direction of the effect was similar to that in the discovery cohort. After meta-analyzing both samples, we found a more significant P value for rs1537372 (n=2750; P=1.38×10 −10 ) and a less significant P value for rs11038042 (n=2765; P=2.99×10 −7 ).
Discussion
In this population-based study, we examined the contribution of common genetic variants to ICAC, for which the genetic basis is currently unknown. We found a high heritability of ICAC volume and identified 2 loci that influence ICAC, 1 of which replicated in an independent cohort of patients with stroke. Strengths of our study are the quantitative assessment of ICAC volume, and the fact that the results remained unchanged after excluding participants with a previous clinical stroke. There are also methodological considerations to take into account. First, it is important to keep in mind that calcification is thought to represent atherosclerosis but represents only a part of the total atherosclerotic plaque. With nonenhanced CT, it is not possible to visualize the noncalcified plaque components. Yet, extensive evidence demonstrates that calcification volume is an adequate indicator of the total underlying atherosclerotic burden. 21, 22 Second, our analyses were performed on relatively small samples, both the discovery and replication sample. Yet, this is a direct consequence of the lack of other studies that have quantitatively assessed ICAC as well as performed genome-wide genotyping and that could have been used to increase the study population and hence the statistical power of the association. Nonetheless, we were able to obtain genome-wide significant variants and heritability estimates for intracranial atherosclerosis. A final consideration is that we used the genome-wide complex trait analysis to determine the heritability estimates, which are measures of the additive heritability, representing narrow-sense heritability. 13 This directly means that only the additive effects of the genes are taken into account, leaving nonadditive effects unstudied.
We found a heritability of >47% for ICAC, which is comparable with the heritability of coronary artery calcification, which we found to be 52%. One previous report on the heritability of coronary artery calcification quantity showed a heritability of 44%. 23 In contrast, we found that for calcification in the carotid artery bifurcation only 17% was attributable to genetic factors, and aortic arch calcification was heritable for 36%. These differences in genetic contribution to the development of calcification in different vessel beds shed light on the previously reported variation in atherosclerotic burden across various vessel beds. 7, 8, 24 In addition to its high heritability, we also identified multiple genome-wide significant variants for ICAC at 2 loci. The first locus, on which we found 28 variants that were associated with ICAC, was located on chromosome 9, near the CKDN2a/CKDN2b genes. In the METASTROKE collaboration, 20 the 9p21.3 locus has previously been implicated in ischemic strokes, which were classified as strokes caused by large-vessel disease on the basis of the TOAST (Trial of ORG 10172 in Acute Stroke Treatment) criteria. Although even using tens of thousands of samples, this did not reach genomewide significance even. Remarkably, we robustly identify a strong signal in only 2000 individuals and show that this locus likely increases risk of stroke through calcifications in the intracranial carotid artery. Future large-collaborative research is needed to clarify this further. Besides its associations with stroke, variants at 9p21 have been related to coronary artery calcification volume and myocardial infarction. 5 In fact, the top variant found in the GWAS on these traits, rs1333049, was in our study also strongly associated (P=1.70×10 −8 ) with ICAC volume. Earlier, we found that this variant was also 
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associated with aortic arch calcification and calcification in the carotid artery bifurcation. 6 Also, associations with the 9p21 locus have been found for vascular stiffness 25 and aneurysms of the abdominal aorta, 26 suggesting a broad influence on arterial disease. Of particular note is a recent publication on how 9p21.3 risk variants disrupt specific transcription factor-dependent transforming growth factor-β regulation of p16 expression in human aortic smooth muscle cells. 27 An interesting hypothesis would be that this same mechanism is responsible for vascular disease in other vessel beds by affecting smooth muscle cells locally, such as in the carotid arteries, providing a potential mechanism on how the risk variants influence vascular disease.
We identified another variant in the 11p11.2 region on chromosome 11 that associated with ICAC volume. Although we were unable to replicate this finding, this was an interesting association, especially because this 11p11.2 locus is not known for associations with subclinical vascular disease or cardiovascular events. However, this region has been linked to fasting glucose homeostasis and a higher risk of type 2 diabetes mellitus. 28 Interestingly, diabetes mellitus is one of the strongest known risk factors for ICAC. 4, 29 Finally, we identified a variant on 2q14.1, which showed a suggestive association with ICAC. The DPP10 gene, which is closely located to the variant that we identified, is primarily known for its influence on asthma. 30 The exact mechanisms underlying the associations of these loci with ICAC need further elucidation from future studies.
In summary, ICAC volume is a heritable trait, which is explained by common genetic variation. Moreover, we identified and replicated 1 variant at locus 9p21.3, which is known for its contribution to ischemic stroke. Given the importance of ICAC in the development of stroke, larger-scale studies to further elucidate the genetic basis of intracranial atherosclerosis are needed. 
